logo

Arcus Biosciences, Inc (RCUS)



Trade RCUS now with
  Date
  Headline
2/1/2021 8:06:07 AM Gilead Sciences To Raise Ownership Stake In Arcus To 19.5%, To Buy About 5.65 Mln Addl. Shares For $39/shr
1/15/2021 8:17:51 AM Arcus Biosciences Presents Promising Initial Data From Phase 1 Portion Of ARC-8 Study For AB680
1/6/2021 4:51:52 PM Arcus Biosciences Appoints Andrew Perlman And Michael Quigley To Its Board Of Directors
12/9/2020 7:57:00 PM Arcus Biosciences Expands Partnerships With WuXi Biologics To Develop Anti-CD39 Antibody For Treatment Of Cancer
10/29/2020 7:52:25 AM Arcus To Collaborate With AstraZeneca On Registrational Trial For Domvanalimab Plus Imfinzi In Stage III NSCLC
7/7/2020 4:20:40 PM Arcus Biosciences Appoints Bob Goeltz As CFO
5/28/2020 11:09:50 PM Arcus Biosciences Prices Underwritten Public Offering Of 11 Mln Shares At $27.50/shr
5/27/2020 7:14:09 AM Gilead Sciences, Arcus Biosciences Enter 10-year Partnership To Co-develop Cancer Immunotherapies
5/26/2020 4:14:33 PM Arcus Biosciences Appoints David Lacey To Its Board Of Directors
3/11/2020 8:02:58 AM Arcus Biosciences Announces New Employment Inducement Grants
2/26/2020 8:16:44 AM Arcus Biosciences, Taiho Pharma Announce Taiho's Exercise Of Its Option For License To AB122 In Japan& Asian Countries
12/12/2019 9:06:30 AM Arcus Biosciences Adds Patrick Machado To Board
3/8/2019 6:58:57 AM Wedbush Is Raising Arcus Biosciences, Inc (RCUS) FY19 Estimate To -1.42 From -1.93